| Breast cancer classification and prognosis based on gene expression profiles from a population-based study C Sotiriou, SY Neo, LM McShane, EL Korn, PM Long, A Jazaeri, P Martiat, ... Proceedings of the National Academy of Sciences 100 (18), 10393-10398, 2003 | 2712 | 2003 |
| The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ... Annals of oncology 26 (2), 259-271, 2015 | 2652 | 2015 |
| Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ... Journal of the National Cancer Institute 98 (4), 262-272, 2006 | 2324 | 2006 |
| International network of cancer genome projects Data coordination centre Kasprzyk (Leader) Arek 1 Stein (Leader) Lincoln D ... Nature 464 (7291), 993-998, 2010 | 2249 | 2010 |
| Landscape of somatic mutations in 560 breast cancer whole-genome sequences S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ... Nature 534 (7605), 47-54, 2016 | 2166 | 2016 |
| Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ... Journal of the National cancer Institute 103 (22), 1656-1664, 2011 | 2026 | 2011 |
| Gene-expression signatures in breast cancer C Sotiriou, L Pusztai New England Journal of Medicine 360 (8), 790-800, 2009 | 1915 | 2009 |
| The landscape of cancer genes and mutational processes in breast cancer PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ... Nature 486 (7403), 400-404, 2012 | 1907 | 2012 |
| 70-gene signature as an aid to treatment decisions in early-stage breast cancer F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ... New England Journal of Medicine 375 (8), 717-729, 2016 | 1854 | 2016 |
| Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition … S Loi, N Sirtaine, F Piette, R Salgado, G Viale, F Van Eenoo, G Rouas, ... Journal of clinical oncology 31 (7), 860-867, 2013 | 1749 | 2013 |
| Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ... Journal of the National Cancer Institute 98 (17), 1183-1192, 2006 | 1507 | 2006 |
| Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial S Loi, S Michiels, R Salgado, N Sirtaine, V Jose, D Fumagalli, ... Annals of oncology 25 (8), 1544-1550, 2014 | 1358 | 2014 |
| Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients E de Azambuja, F Cardoso, G de Castro, M Colozza, MS Mano, ... British journal of cancer 96 (10), 1504-1513, 2007 | 1293 | 2007 |
| Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative … C Denkert, G Von Minckwitz, JC Brase, BV Sinn, S Gade, R Kronenwett, ... J Clin oncol 33 (9), 983-991, 2015 | 1099 | 2015 |
| Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ... Clinical cancer research 13 (11), 3207-3214, 2007 | 1088 | 2007 |
| Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ... Breast Cancer Research 10, 1-11, 2008 | 1045 | 2008 |
| CD4+ follicular helper T cell infiltration predicts breast cancer survival C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ... The Journal of clinical investigation 123 (7), 2873-2892, 2013 | 1014 | 2013 |
| Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade S Loi, B Haibe-Kains, C Desmedt, F Lallemand, AM Tutt, C Gillet, P Ellis, ... Journal of clinical oncology 25 (10), 1239-1246, 2007 | 943 | 2007 |
| Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes C Desmedt, B Haibe-Kains, P Wirapati, M Buyse, D Larsimont, ... Clinical cancer research 14 (16), 5158-5165, 2008 | 941 | 2008 |
| HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures H Davies, D Glodzik, S Morganella, LR Yates, J Staaf, X Zou, ... Nature medicine 23 (4), 517-525, 2017 | 919 | 2017 |
